Access Relievant Medsystems Stock and Financial Details

Relievant Medsystems Funding Rounds and Valuation

Funding History Chart

Funding Round Details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	03/17/2023	Series G	$50MM	$xx.xx	$361.21MM	Undisclosed Investors
Price per Share $xx.xx Shares Outstanding 458,513,658 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.2x Dividend Rate 6.8% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Undisclosed Investors
	10/29/2020	Series F	$69.7MM	$xx.xx	$360.34MM	Canaan Partners, Endeavour Vision, Lightstone Ventures, Morgenthaler Ventures, New Enterprise Associates, Vensana Capital
Price per Share $xx.xx Shares Outstanding 749,797,752 Liquidation Pref Order 2 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Canaan Partners, Endeavour Vision, Lightstone Ventures, Morgenthaler Ventures, New Enterprise Associates, Vensana Capital
	06/26/2018	Series E	$59.31MM	$xx.xx	$115.23MM	Canaan Ventures, Emergent Ventures, Endeavour Vision, Morgenthaler, New Enterprise Associates, Rk Mellon
Price per Share $xx.xx Shares Outstanding 638,057,194 Liquidation Pref Order 3 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Canaan Ventures, Emergent Ventures, Endeavour Vision, Morgenthaler, New Enterprise Associates, Rk Mellon
	10/11/2016	Series D-1	$23.16MM	$xx.xx	$90.33MM	Canaan Partners, Emergent Medical Partners, Morgenthaler, New Enterprise Associates
Price per Share $xx.xx Shares Outstanding 90,579,887 Liquidation Pref Order 4 Liquidation Pref As Multiplier 1.0x Conversion Ratio 2.8x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Canaan Partners, Emergent Medical Partners, Morgenthaler, New Enterprise Associates
	03/28/2012	Series D	$25.77MM	$xx.xx	$64.66MM	Canaan Partners, Emergent Medical Partners, Morgenthaler, New Enterprise Associates, Onset Ventures
Price per Share $xx.xx Shares Outstanding 100,808,708 Liquidation Pref Order 4 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.5x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Canaan Partners, Emergent Medical Partners, Morgenthaler, New Enterprise Associates, Onset Ventures
	07/07/2009	Series C	$15.17MM	$xx.xx	$42.55MM	Canaan Partners, Emergent Medical Partners, Morgenthaler, Onset Ventures
Price per Share $xx.xx Shares Outstanding 30,348,556 Liquidation Pref Order 5 Liquidation Pref As Multiplier 1.0x Conversion Ratio 2.3x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Canaan Partners, Emergent Medical Partners, Morgenthaler, Onset Ventures
	10/22/2006	Series B-1	$2.03MM	$xx.xx	$15.52MM	Bcm Technologies, Canaan Partners, Onset Ventures
Price per Share $xx.xx Shares Outstanding 2,976,497 Liquidation Pref Order 5 Liquidation Pref As Multiplier 1.0x Conversion Ratio 3.1x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Bcm Technologies, Canaan Partners, Onset Ventures
	10/22/2006	Series B	$2.51MM	$xx.xx	$15.52MM	Bcm Technologies, Canaan Partners, Onset Ventures
Price per Share $xx.xx Shares Outstanding 4,972,228 Liquidation Pref Order 5 Liquidation Pref As Multiplier 1.0x Conversion Ratio 2.3x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Bcm Technologies, Canaan Partners, Onset Ventures

Access Stock Price

Leadership & Board

Leadership

Tyler Binney

Chief Executive Officer, President & Board Member

Christopher Geyen

Chief Financial Officer

Rex Peters

Co-Founder & Chief Operating Officer

Ray Baker MD

Chief Medical Officer

Board

Alexander Schmitz

Endeavour Vision

Arthur Taylor

Vensana Capital

Brenton Ahrens

Canaan Partners

Ross Jaffe MD

New Enterprise Associates

Jason Lettmann

Morgenthaler Ventures

Relievant Medsystems stock FAQs

Can you buy Relievant Medsystems stock?

You can no longer buy Relievant Medsystems stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Relievant Medsystems stock?

Can you sell Relievant Medsystems stock?

You can no longer sell stock of Relievant Medsystems on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Relievant Medsystems stock?

Is Relievant Medsystems a public company?

Relievant Medsystems is now a public company.

What is Relievant Medsystems’ stock price?

The stock price of Relievant Medsystems is not currently available.

What is Relievant Medsystems’ stock ticker symbol?

The ticker symbol of Relievant Medsystems is not currently available.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Relievant Medsystems News and Media Highlights

Blog

Startup News: Acquired companies, a look back for 2023

December 21, 2023

An initial public offering may be the desired outcome for the founders of many private companies. But in a stock market that hasn’t been particularly kind in the past year to a few startups that have made public debuts, a well-priced exit via acquisition could be more appealing to investors.

Reuters 09/19/2023

Boston Scientific to buy chronic back pain therapy maker Relievant

Medical devices maker Boston Scientific (BSX.N) said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million, gaining access to an FDA-cleared therapy for chronic pain. The Massachusetts-based company is also obliged to pay Relievant additional undisclosed payments based on sales performance over the next three years.

Globe Newswire 02/22/2023

Relievant Medsystems Announces Formal Coverage Recommendation from NASS for Basivertebral Nerve Ablation as a Treatment for Chronic Vertebrogenic Low Back Pain

Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the North American Spine Society (NASS) issued a formal coverage recommendation supportive of basivertebral nerve (BVN) ablation for the treatment of chronic vertebrogenic low back pain.

Last Funding Round
AliveCor	--	$xx.xx	Series F	$943.68MM	$xx.xx	$150MM
Beta Bionics	--	$xx.xx	--	--	--	--
CMR Surgical	--	$xx.xx	--	--	--	--
Cresilon	--	$xx.xx	--	--	--	--
Elixir Medical	--	$xx.xx	--	--	--	--
HistoSonics	--	$xx.xx	Series D-1	$598.27MM	$xx.xx	$102.7MM
Levels	--	$xx.xx	Series A-1	$311.7MM	$xx.xx	$46.01MM
Neocis	--	$xx.xx	Series D	$320.32MM	$xx.xx	$112MM
Neuralink	$44.88	$xx.xx	Series D	$3.45B	$xx.xx	$281.55MM
Synchron	--	$xx.xx	Series C	$400.53MM	$xx.xx	$74.13MM

Updated on: Dec 3, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

Updated on: Dec 3, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.
The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.

Relievant Medsystems Stock

Register To Buy and Sell Private Company Shares

Relievant Medsystems Stock Price

Relievant Medsystems Funding Rounds and Valuation

Relievant Medsystems Investors Also Invested in These Private Companies